|
|
|
Insider
Information: |
Mclaughlin Gerald W. |
Relationship: |
Director |
City: |
Conshohocken |
State: |
PA |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
3 |
|
Direct
Shares |
92,651 |
|
Indirect Shares
|
0 |
|
|
Direct
Value |
$321,917 |
|
|
Indirect Value
|
$0 |
|
|
Total
Shares |
92,651 |
|
|
Total
Value |
$321,917 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
0
|
0
|
Stock
price went up :
|
0
|
0
|
Stock
price went down : |
0
|
0
|
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
Percentage
Gain/Loss : |
0.0%
|
0.0%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Skye Bioscience Inc |
SKYE |
Director |
2015-10-20 |
61,250 |
2015-08-20 |
0 |
Premium* |
|
Neos Therapeutics, Inc. |
NEOS |
Chief Executive Office... |
2021-03-19 |
0 |
2018-12-04 |
0 |
Premium* |
|
AYTU BIOSCIENCE, INC |
AYTU |
Director |
2021-04-08 |
31,401 |
|
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
9 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 1 of 1
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
NEOS |
Neos Therapeutics, Inc. |
Chief Executive Officer |
|
2018-12-04 |
4 |
B |
$2.04 |
$15,120 |
D/D |
7,403 |
7,403 |
2.81 |
- |
|
NEOS |
Neos Therapeutics, Inc. |
Chief Executive Officer |
|
2018-12-06 |
4 |
B |
$2.11 |
$36,119 |
D/D |
17,097 |
24,500 |
2.81 |
- |
|
NEOS |
Neos Therapeutics, Inc. |
Chief Executive Officer |
|
2020-03-02 |
4 |
A |
$0.00 |
$0 |
D/D |
290,000 |
314,500 |
0 |
- |
|
NEOS |
Neos Therapeutics, Inc. |
Chief Executive Officer |
|
2021-03-02 |
4 |
D |
$0.84 |
$37,414 |
D/D |
(44,329) |
270,171 |
0 |
- |
|
NEOS |
Neos Therapeutics, Inc. |
Chief Executive Officer |
|
2021-03-19 |
4 |
D |
$0.00 |
$0 |
D/D |
(270,171) |
0 |
0 |
- |
|
SKYE |
Skye Bioscience Inc |
Director |
|
2015-08-20 |
4 |
A |
$0.00 |
$0 |
D/D |
31,250 |
31,250 |
0 |
- |
|
SKYE |
Skye Bioscience Inc |
Director |
|
2015-10-20 |
4 |
A |
$0.00 |
$0 |
D/D |
30,000 |
61,250 |
0 |
- |
|
AYTU |
AYTU BIOSCIENCE, INC |
Director |
|
2021-03-19 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
24,901 |
|
- |
|
AYTU |
AYTU BIOSCIENCE, INC |
Director |
|
2021-04-08 |
4 |
A |
$0.00 |
$0 |
D/D |
6,500 |
31,401 |
0 |
- |
|
9 Records found
|
1
|
Page 1 of 1 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|